Screener
TransCode Therapeutics, Inc. RNAZ Q4 2025 earnings
Reported April 15, 2026
EPS-$16.42Miss by $6.34
EPS estimate-$10.08
Next report
Nov 18, 2026 (In 2 weeks)Versus estimates
Diluted EPS
Q2 2026-$7.17Q1 2026-$21.28
Q4 2025-$16.42Miss by $6.34
Q3 2025-$5.49Beat by $3.75Q2 2025-$4.94Beat by $3.74Q1 2025-$16.81Miss by $13.60FAQ
- When did TransCode Therapeutics, Inc. report Q4 2025 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q4 2025 earnings on April 15, 2026.
- What were TransCode Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-16.42 for Q4 2025.
- Did TransCode Therapeutics, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-10.08 by $6.34.
- How did TransCode Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 1.2% from $-16.61.
